Progression-free survival in patients in with advanced ovarian cancer defined by GCIG criteria vs. RECIST criteria: Analysis of the secondary endpoint of the AGO-Ovar16 trial
ONCOLOGY RESEARCH AND TREATMENT(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要